Heart Disease Risk Prediction System Based on KNN Algorithm: A Complete Practice from Data to Deployment

This article introduces an open-source project that demonstrates how to build an end-to-end heart disease risk prediction web application from data preprocessing and model training to Streamlit deployment. The system, with the K-Nearest Neighbors (KNN) algorithm at its core, aims to serve as an auxiliary tool for clinical decision-making and help identify heart disease risks early. The project uses Scikit-learn to implement the model and Streamlit for rapid deployment, embodying the "Minimum Viable Product" (MVP) concept.

Heart disease is the leading cause of death globally, and early risk identification is crucial for preventive intervention. With the popularization of wearable devices and electronic medical records, machine learning prediction systems have become clinical auxiliary tools. This project is an end-to-end web application, and its core technology stack includes: KNN classifier (simple, intuitive, and easy to interpret), Scikit-learn (machine learning foundation), and Streamlit (rapid webization), supporting real-time input of patient data and instant risk prediction.

Core of KNN Algorithm: Based on instance-based learning, it assumes that similar data points are close to each other. When making predictions, it finds the nearest K neighbors and takes a vote. Advantages in heart disease prediction: non-parametric (suitable for complex medical data), interpretable (displays neighbor samples), no training phase required, and supports multi-class classification. Key points for parameter tuning: selecting K value via cross-validation, choosing distance metrics, and feature scaling.

Data Preprocessing: Missing values are filled with median (for numerical data) or mode (for categorical data); categorical encoding and feature standardization are performed; stratified sampling is used to split training/test sets to avoid bias.

Dataset Features: Includes demographic indicators (age, gender), physiological indicators (resting blood pressure, cholesterol, blood glucose), ECG features (resting ECG, exercise-induced angina, ST-segment depression), lifestyle factors (chest pain type, peak exercise heart rate, number of vessels), and other clinical indicators.

Model Evaluation: Uses metrics such as accuracy, sensitivity (recall), specificity, ROC-AUC, and confusion matrix. Limitations of KNN: high computational complexity, curse of dimensionality, large storage requirements, and class imbalance issues.

Interface Design: The sidebar separates input and result areas, provides real-time feedback on input changes, uses progress bars/dashboards to display risk levels, and shows key influencing factors to enhance trust.

Deployment Architecture: Supports local running (development and testing), cloud deployment (Streamlit Cloud/Heroku), and Docker containerization to ensure environment consistency.

Positioning: The system is an auxiliary tool and cannot replace doctors' judgments. Risk scores need to be comprehensively evaluated in combination with clinical manifestations and other factors.

Ethical Privacy: Patient data must be encrypted during storage and transmission; informed consent is required before use; ensure the model's fairness across different populations.

Continuous Improvement: Monitor model performance decay, establish a feedback loop to update the model using actual diagnosis results, and support incremental learning.

Expansion Directions: Algorithm upgrades (ensemble methods, deep learning, survival analysis); multi-modal data fusion (genomics, imaging, time-series data); personalized medicine (patient stratification, dynamic risk, intervention recommendations).

Summary: This project demonstrates the application path of machine learning in clinical decision support. Technical decisions balance practicality and usability. Although there is room for optimization, the end-to-end model provides a reference framework for medical AI and will play a more significant role in chronic disease management in the future.